Fletcher Allen, a Vermont university hospital and medical center, serves all of
Vermont and the northern New York region. Located in Burlington, Fletcher Allen is a regional, academic healthcare center and teaching hospital in alliance with the University of Vermont.
University of Vermont Hematology/Medical Oncology Fellowship
The combined Hematology/Medical Oncology Fellowship training program consists of a minimum of three years of training. Every attempt is made to individualize the program to the specific interests and needs of the Fellow by maintaining maximum flexibility beyond the basic requirements set forth by the Accrediting Council for Graduate Medical Education (ACGME). Overall, the program is designed to produce broadly competent professionals with scholarly strengths who have the potential to pursue academic or clinical practice careers.
The University of Vermont College of Medicine and its main, on-campus tertiary care teaching hospital, Fletcher Allen, offers a program designed to effectively prepare physicians for successful ABIM board certification in both Hematology and Medical Oncology.
The clinical faculty physicians within the Hematology/Oncology Division, have full time academic appointments in the Department of Medicine and are members of the Vermont Cancer Center, which offers many cancer research opportunities for Fellows in laboratory and clinical fields. For example, the Hemostasis and Thrombosis research training track is embedded within the Hematology/Oncology Fellowship, and offers a spectrum of attractive clinical and research opportunities for an interested Fellow. This track is supported by a National Institutes of Health training grant.
The Vermont Cancer Center's outpatient Hematology/Medical Oncology clinics as well as the disease-specific Multidisciplinary Clinics (MDCs), are located conveniently in the Fletcher Allen Ambulatory Care Center which is immediately adjacent to the main hospital and enhances the Fellow's clinical experiences in both the inpatient and outpatient settings.
Julian Sprague, MD, PhD